首页|感染翻修术后早期假体周围感染再清创的疗效分析

感染翻修术后早期假体周围感染再清创的疗效分析

扫码查看
目的:分析清创保留假体联合抗生素(DAIR)治疗感染翻修术后早期假体周围感染(PJI)的临床效果.方法:回顾性分析2011年1月至2020年12月新疆医科大学第一附属医院收治的采用DAIR治疗104例早期PJI患者的临床资料.根据既往有无翻修手术史分为翻修手术组25例和初次手术组79例,两组患者的年龄、性别、感染部位、体重指数(BMI)、红细胞沉降率(ESR)、C反应蛋白(CRP)比较,差异均无统计学意义(P均>0.05).比较两组患者的治疗成功率、致病菌、美国膝关节协会评分(KSS)、Harris髋关节评分(HHS)及术后并发症发生情况.结果:翻修手术组患者获得0.3~127.0个月随访,平均(51.9±43.7)个月;初次手术组患者获得0.6~131.0个月随访,平均(63.5±40.0)个月.末次随访时,翻修手术组的治疗成功率为56.0%(14/25),低于初次手术组86.1%(68/79)(P<0.05);翻修手术组中既往单次翻修手术史PJI治愈率为75.0%(12/16),高于既往2次及以上翻修手术史PJI的治愈率22.2%(2/9)(P<0.05).翻修手术组(71.4%)和初次手术组(82.4%)金黄色葡萄球菌治疗成功率比较,差异无统计学意义(P>0.05).翻修手术组患者KSS和HHS分别由术前(36.2±8.1)分和(41.4±6.5)分提高至(64.7±11.7)分和(70.7±11.1)分(P均<0.001).初次手术组患者KSS和HHS由术前(39.4±7.6)分和(44.0±7.2)分提高至(80.2±8.2)分和(81.7±6.7)分(P均<0.001).翻修手术组患者术后KSS和HHS均低于初次手术组(P均<0.05).翻修手术组患者术后并发症发生率为56.0%(14/25),高于初次手术组的24.1%(19/79)(P<0.05).结论:DAIR治疗既往有翻修手术史的早期PJI效果欠佳,而对于2次及以上翻修术后的早期PJI,则不建议使用DAIR治疗.
Efficacy of debridement for early prosthetic joint infection following revision surgery
Objective:To analyze the clinical efficacy of debridement,antibiotics and implant retention(DAIR)combined with intra-articular antibiotic administration in the management of early prosthetic joint infection(PJI)following revision infection.Methods:A retrospective analysis of clinical data of 104 patients with early PJI treated with DAIR combined with intra-articular antibiotic administration at the First Affiliated Hospital of Xinjiang Medical University from January 2011 to December 2020.Patients were divided into revision arthroplasty group(25 cases)and primary arthroplasty group(79 cases)based on their surgical history.Baseline characteristic,including age,gender,infection site,body mass index(BMI),erythrocyte sedimentation rate(ESR),or C reactive protein(CRP)levels,were comparable between the two groups.Treatment success rates,pathogens,the Knee Society Score(KSS),the Harris Hip Score(HHS),and postoperative complications were compared between the two groups.Results:The revision surgery group had a follow-up period ranging from 0.3 to 127.0 months,with an average of(51.9±43.7)months,while the primary surgery group had a follow-up period ranging from 0.6 to 131.0 months,with an average of(63.5±40.0)months.At the final follow-up,the treatment success rate was significantly lower in the revision surgery group(56.0%,14/25)compared to the primary surgery group(86.1%,68/79)(P<0.05).In the revision surgery group,the cure rate for PJI was significantly higher in patients with a single revision(75%,12/16)compared to those with multiple(≥2)revisions(22.2%,2/9)(P<0.05).There was no statistically significant difference in the success rate for S.aureus infection between the revision(71.4%)and the primary(82.4%)surgery groups(P>0.05).The KSS and HHS in the revision surgery group improved from(36.2±8.1)and(41.4±6.5)preoperatively to(64.7±11.7)and(70.7±11.1)postoperatively,respectively(both P<0.001).In the primary surgery group,the KSS and HHS improved from(39.4±7.6)and(44.0±7.2)preoperatively to(80.2±8.2)and(81.7±6.7)postoperatively,respectively(both P<0.001).The postoperative KSS and HHS in the revision surgery group were significantly lower than those in the primary surgery group(both P<0.05).The incidence of postoperative complications was higher in the revision surgery group(56.0%,14/25)compared to the primary surgery group(24.1%,19/79)(P<0.05).Conclusions:DAIR is less effective in treating early PJI in patients with a history of revision surgery.DAIR is not recommended for treating early PJI with multiple(≥2)prior revision surgeries.

RevisionPrimaryEarlyProsthetic Joint InfectionDebridement with Implant Retention

陈权、曹力、张晓岗

展开 >

新疆医科大学第一附属医院关节外科,乌鲁木齐 830054

翻修 初次 早期 假体周围感染 保留假体清创术

国家自然科学基金青年基金项目新疆维吾尔自治区自然科学基金新疆维吾尔自治区科技计划重大科技专项项目新疆维吾尔自治区科学技术厅"科技创新团队"项目

820022762022D01D562022A030112023TSYCTD0014

2024

中华骨与关节外科杂志
中国医学科学院 中国协和医学院

中华骨与关节外科杂志

CSTPCD北大核心
影响因子:0.906
ISSN:2095-9958
年,卷(期):2024.17(7)
  • 4